BMRH physicians publish in rehab journal

 

BMRH’s Brian McDonald, DO and Mithra Maneyapanda, MD, along with Thomas Jefferson University’s Jessica Calandra, MD, presented a poster entitled, “Inpatient Rehabilitation of Delayed Post-Hypoxic Leukoencephalapothy: A Case Report,” at the American Academy of Physical Medicine & Rehabilitation (AAPM&R) annual assembly in Orlando, FL on October 25. The abstract appears in the Physical Medicine & Rehabilitation Journal.

 

Posted in Clinician News | Tagged | Leave a comment

Upcoming events

Upcoming Events

Posted in Clinician News | Tagged | Leave a comment

Best read of the week

Healthcare’s Most Wired
CHIME Healthcare: Recognizing the best in healthcare IT 2018.

Additional news media reports on MLH physicians and the health care industry, excerpted from MLH’s daily Morning News Report:

Main Line Health…

2018 Top Doctors
Main Line Today: Here are the best practitioners around the Main Line and western suburbs.

Regional News…

Philadelphia launches push to get hospitals and universities to buy local
Philadelphia Inquirer: Philadelphia’s vast eds and meds community represents not only academic and research strength, but considerable buying heft. Across the same city, thousands of local companies are eager for some of that business but are shut out.

Health Business News…..

 

Trump Administration Invites Health Care Industry to Help Rewrite Ban on Kickbacks
The New York Times: The administration wants to open pathways for hospitals and doctors to work together to improve care and save money. The challenge will be to accomplish that without also increasing the risk of fraud.

Quality and Safety News…

 

One Twin’s Difficult Birth Puts A Project Designed To Reduce C-Sections To The Test
Kaiser Health News: This is the story of how that baby, Bryce McDougall, tested the best efforts of more than a dozen medical staffers at South Shore Hospital in Weymouth, Mass., that day last summer.

Patient Care News…

 

Heart Transplant Candidate Patient’s Letter from Spectrum Health Goes Viral
WHTC: Hedda Martin survived breast cancer, but chemotherapy damaged her heart. She needs a heart transplant.

Posted in Clinician News | Tagged | Leave a comment

Richard Ing, MD presents at ObesityWeek 2018 in Nashville

On Thursday, November 15, Dr. Ing presented his research paper: Multimodality Postoperative Pain Management in Bariatric Patients, at ObesityWeek in Nashville, Tennessee.

ObesityWeek is a unique, international event focused on the basic science, clinical application, surgical intervention and prevention of obesity. By combining both American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS) annual meetings, ObesityWeek brings together world-renowned experts in obesity to share innovation and breakthroughs in science unmatched around the globe.  It is the leading conference of its kind with a multi-track schedule including keynote speakers, and video/poster presentations, as well as pre-conference courses, research and education sessions, and hands-on skills labs.

For more information about Main Line Health’s bariatric program visit www.mainlinehealth.org/bariatrics.

Posted in Clinician News | Tagged | Leave a comment

Main Line Health System chief of cardiovascular disease presented positive one-year results for new peripheral vascular study

William A. Gray, MD, system chief of the division of cardiovascular disease at Main Line Health and president of Lankenau Heart Institute, led the first peripheral vascular clinical study to enroll patients with 100% dissected vessels. He presented the one-year results of the study at the annual Vascular InterVentional Advances conference held in Las Vegas Nov. 5-8.

The Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial, on which Dr. Gray was the principal investigator, enrolled 213 patients at 33 U.S. and European sites. Researchers sought to determine how effectively the Tack Endovascular System (Intact Vascular, Inc.) was able to repair femoropopliteal arteries following standard balloon angioplasty. All patients in the study had peripheral artery disease, had undergone balloon angioplasty and had experienced at least one dissection, with close to 70 percent classified as severe.

The study found that 92 percent of dissections were successfully resolved with the use of the Tack Endovascular System. At 12 months, results included improved vessel patency (79% Kaplan-Meier), and freedom from clinically driven reintervention was 86% (Kaplan-Meier). The TOBA II study also demonstrated the Tack implants to be stable and durable, with zero implant fractures, 99.9% freedom from migration, and a 0.5% bailout stent rate. Compared to predicate data from prior balloon angioplasty, these results represented an improvement in one-year outcomes.

“The TOBA II study is unique in that it is the first large-scale pivotal evaluation in peripheral arterial vessels that are 100% dissected following initial angioplasty and treated with a precisely targeted implant,” said Dr. Gray, who also serves as a clinical professor of the Lankenau Institute for Medical Research, the research division of Main Line Health. “This study introduces a new therapeutic paradigm, demonstrating that we can repair dissected arteries, leaving minimal metal behind to preserve future treatment options for our patients, and producing excellent 12-month outcomes.”

Posted in Clinician News | Tagged | Leave a comment

Email message changes being implemented across the System

By John Abella, System director, Information Security and Enterprise Architecture

 As part of our continuous assessment and improvement of Information Security at Main Line Health, we’re implementing changes to how we label email messages that originate from outside of MLHS.

Currently, any message that originates from outside of our network has the subject modified to say [EXTERNAL], as well as a banner warning across the first line of the message. This week we’re adding a new subject message that will show up as [PARTNER].

Messages labeled as [PARTNER] are from a very small number of business partners that have regular email exchanges with MLHS employees, including vendors like Independence Blue Cross, Vanguard, Taleo, and others. The initial set of approved business partners has been vetted by Senior Management as well as our Information Security team.

Messages labeled as [PARTNER] should still be examined carefully and any suspicious messages should be sent to the IT Service Desk (helpdesk@mlhs.org) for analysis.  Being tagged as [PARTNER] doesn’t guarantee a message is safe, just that it originated from a business partner that we generally trust.

Thank you for your continued support and engagement in keeping our organization safe and secure.

 

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Device study for patients with severe mitral valve regurgitation

By Donna Loyle, communications specialist, LIMR

The APOLLO clinical trial (#3809) is for patients who’ve been diagnosed with severe symptomatic mitral regurgitation and who’ve been told they need mitral valve replacement. This is a multi-center, global, prospective, interventional, pre-market trial with two subject groups randomized on a 1:1 basis to either the study device or to conventional mitral valve surgery.

One group of participants will have the Medtronic Intrepid™ transcatheter mitral valve replacement system (TMVR) implanted in their mitral valve, while the other group will undergo conventional surgical mitral valve replacement.

Additionally, patients who are unable to undergo surgical replacement may qualify for the TMVR procedure.

Subjects are seen at pre- and post-procedure, discharge, 30 days, six months, and annually through five years.

Patient must be deemed a candidate for bioprosthetic mitral valve replacement; must not have prohibitive mitral annular calcification or hemodynamic instability; and must not have left ventricular ejection fraction <25%.

If you have identified a patient who may benefit from this treatment, an evaluation can be performed by the Structural Heart Team at Lankenau Heart Institute. The principal investigator is Dr. Scott Goldman, and sub-investigators are Dr. William Gray and Dr. Sandra Abramson. More information is available at https://www.mainlinehealth.org/research/clinical-trials/3809-apollo

 

Posted in Clinician News | Tagged | Leave a comment

Sharpe-Strumia Research Foundation: January 16 application deadline for funding opportunities

Grants are available to support original research by health care professionals at Bryn Mawr Hospital and other Main Line Health hospitals.

Priority will be given to research proposals by practicing physicians and other healthcare professionals at Bryn Mawr Hospital.  Projects that have the potential to lead to advances in clinical practice are encouraged.

Funds for travel to national meetings for presentation of results are available with prior approval from the Treasurer.  Reimbursement for publication costs of funded studies in peer reviewed journals is available.

A maximum of $50,000 per project is available for a period of 1 year starting on July 1, 2019.  A few grants will be considered for an award of $75,000 IF THERE IS CLEAR JUSTIFICATION in the research and budget sections explaining why the additional funds are crucial to the project.  Most awards will be for $50,000 in an effort to encourage as many research projects as possible.  If the project is not completed within one year, the investigator may apply for funding in the next funding cycle.

Assistance in refining your research proposal prior to submission is available from experienced investigators.  Such assistance is strongly encouraged especially for investigators who do not have extensive research experience.

Investigators agree to abide by the Foundation’s  intellectual property policy which is available on the Foundation’s website (http://www.mainlinehealth.org/sharpe-strumia)

Please visit  http://www.mainlinehealth.org/sharpe-strumia  and/or contact Louise Gethers for information on application forms and procedures.

Submit a complete electronic version of your proposal to: SharpeStrumiaFoundationOffice@MLHS.ORG and seven (7) hardcopies

by noon on January 16, 2019 to:

Louise Gethers

Sharpe – Strumia Research Foundation Office

130 S. Bryn Mawr Avenue

1st Floor / H-Wing, Room 110

Bryn Mawr, PA  19010

For further information: Contact Louise Gethers at (484) 337-4244 or email GethersL@mlhs.org.

Visit us on the web at http://www.mainlinehealth.org/sharpe-strumia

Currently funded projects are listed on the back of this Announcement as examples

 

 

Posted in Clinician News | Tagged | Leave a comment

Agency for Healthcare Research and Quality (AHRQ) Safety Culture Survey results 2018

 By Sharon DiRienzo, director, Patient Safety/Quality/Risk

Some months ago all employees and medical staff were asked to complete a survey about safety culture.  We have utilized the same survey every other year since 2012.  For those without direct or indirect patient care responsibilities a short version is utilized.  This year we also included a brief survey, also created by the AHRQ, about Health Information Technology (HIT) to help hospitals assess the extent to which their culture is sensitive to how the use of health IT affects patient safety from the perspective of the various groups that use it.

The results have been shared with leaders in each of the hospitals and entities that participated.

Some facts and findings from the Safety Culture survey:

  • The overall response rate was 43% (2,952 survey responses)
  • Comparing our composite scores in the 13 domains to the national database (see the figure above):
    • 4 scored in the 50th percentile
    • 8 scored below the 50th percentile
    • 1 scored below the 25th percentile
  • Communication Openness questions (that speak to speaking up for safety and power distance and authority gradient) for clinical staff:
    • The question “staff will freely speak up if they see something that may negatively affect patient care” jumped 4 percentage points from 2016!
    • The power gradient question “staff feel free to question those with more authority” stayed exactly the same.
  • Communication Openness for non-clinical staff:
    • The question about staff speaking up jumped 9 percentage points from 2016!
    • The power gradient question dropped 1 percentage point and was just shy of reaching the 90th percentile ranking.

Findings from the HIT survey:

  • Overall MLH scored close to the pilot group (44 hospitals) in overall satisfaction with the electronic medical record (EMR), being made aware of issues that could lead to errors, and being asked for input to improve the EMR.
Posted in Clinician News | Tagged | Leave a comment

STEEEP Huddle: E for Effective

This week’s STEEEP Huddle topicsubmitted by Nicole Kellett, System director, IT SPO, notes that technology impacts almost all parts of the operational process within MLH.  Upgrades and updates to technology need to have an identified Overall Project Lead to ensure that the appropriate department leaders can raise concerns while documenting the initial response team (and appropriate contact information) in the event of a failure.  By ensuring that technology delivers the intended purpose, MLH can provide a superior experience to our patients, physicians and employees.

The STEEEP Huddle topics are posted on the Performance Excellence 2020 site at landing.mainlinehealth.org/PE2020.

Posted in Clinician News | Tagged | Leave a comment